Base editing of RDEB fibroblasts
Testing the efficacy of genomic base editing in dystrophic epidermolysis bullosa primary fibroblasts...
01 April, 2021
Archive
01 January, 2021
BrB-101
Development of a topical gene-editing treatment to restore Collagen VII...
01 December, 2020
Gene therapy for airway disease
Combined respiratory epithelial cell and gene therapy for amelioration of respiratory symptoms in children with Junctional Epidermolysis Bullosa...
01 October, 2020
RDEB gene-edited skin
Pre-clinical and clinical trial for using gene-edited skin in Recessive Dystrophic Epidermolysis Bullosa...
01 September, 2020
NanoCol
A nanoneedle bandage for topical intracellular COL7A1 gene therapy to accelerate wound healing in RDEB...
01 September, 2018
EBGRAFT
Phase I/II ex vivo gene therapy clinical trial for RDEB using genetically corrected autologous skin equivalent grafts...
01 December, 2016
Next generation genome editing
Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...
01 April, 2016
Ocular stem cell regeneration
Stem cell regeneration of the ocular surface in Recessive Dystrophic Epidermolysis Bullosa...
01 July, 2015
Lenticol F
Phase I study of lentiviral-mediated COL7A1 gene-modified autologous fibroblasts in adults with Recessive Dystrophic Epidermolysis Bullosa...
01 January, 2015
ADSTEM
A phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in adults with Recessive Dystrophic Epidermolysis Bullosa...